During October, the MDLinx editors covered a number of interesting conferences in a number of specialties, including pediatrics, gastroenterology, child and adolescent psychiatry, radiation oncology, neurology, cardiology, optometry, and infectious diseases. Some highlights follow:Read More
MDLinx Blog - Medical News and more.
You’ve probably seen the headlines or read the study. Death rates are rising among lower income middle-aged white Americans while death rates in all other demographics are declining. The projected number of lives lost since 1999—more than half a million—is comparable to the current number of deaths due to the AIDS epidemic, the authors wrote.Read More
This week, the American Cancer Society (ACS) published new guidelines for breast cancer screening, which recommend that women who are at average risk of breast cancer should begin annual mammography screenings at age 45 – rather than at age 40, as previous ACS guidelines had recommended. The ACS also recommends that these annual screenings should continue through age 54, and that women aged 55 and older should then transition to biennial screening, while still having the opportunity to continue screening annually. The recommendations advise women to continue with screening mammography for as long as their overall health is good and they have a life expectancy of 10 years or longer.Read More
In the last month, MDLinx editors covered a number of interesting and cutting edge conferences in a number of specialties, including cardiology, endocrinology, neurology, oncology, pulmonology, and several others.
At the 16th World Conference on Lung Cancer, which took place in Denver, CO, there were a number of interesting presentations, including one on drug regulatory delays, presented by David Stewart, MD, FRCPC, from the University of Ottawa/The Ottawa Hospital in Ottawa, Canada, that looked at how the regulatory process slows progress by increasing drug development costs and produces hindrances that delay approval of useful drugs. Another presentation, by Eric Lim, MB, ChB, MD, MSc, FRCS(C-Th), of the Royal Brompton & Harefield NHS Foundation Trust in London, UK, and Lorraine Pelosof, MD, PhD, from the University of Texas Southwestern Medical Center in Dallas, TX, involved a study on the increase in the number of patients who have never smoked but received a diagnosis of non-small cell lung cancer (NSCLC).Read More
The World Health Organization (WHO) has just released new global guidelines on HIV treatment and prophylaxis. These guidelines state that all infected individuals should receive access to antiretroviral treatment (ART), not just particular categories of infected patients.Read More
Everyone knows that it’s coming: the long-anticipated transition to the use of ICD-10 codes will take place as scheduled on October 1. The Centers for Medicare & Medicaid Services (CMS) has made it clear that all Medicare claims with a date of service on or after October 1, 2015 will be rejected if they don’t contain a valid ICD-10 code. And the question on many people’s minds is, will this transition go smoothly? Or will it be fraught with glitches that will catastrophically affect many healthcare professionals’ ability to be reimbursed for essential services?Read More
Top 5 Mobile Apps in Neurology
Previous posts in our MDLinx Blog have highlighted our favorite mobile apps across all medical specialties, as well as our preferred apps in hematology/oncology and cardiology. In this article, we present our picks for the top 5 mobile apps in neurology.
These tools are great for clinical reference, self testing, and patient education. To view even more of our app reviews in neurology, visit our mobile app center!Read More
On November 24, 2014, the Centers for Disease Control and Prevention (CDC) published the results of a comprehensive 2011 study on HIV diagnosis and treatment showing that out of the estimated 1.2 million persons living with HIV in the United States in 2011, 86% had been diagnosed; 40% were engaged in HIV medical care; 37% were using antiretroviral therapy (ART); and 30% had achieved successful viral suppression. These statistics had remained relatively unchanged since 2009, and presumably have not improved substantially since.Read More
Tags: HIV AIDS
There has been enthusiastic interest in our previous posts reviewing the top 20 apps across all of medicine as well as the top apps in Hematology and Oncology. This week, we turn our attention to our favorite apps in Cardiology. These apps represent valuable clinical reference sources, patient education tools, and calculators – all designed to make practice easier for busy cardiologists.
Look for more app highlights in other specialties coming soon...tell us what you think…and let us know if we've overlooked any apps that you find valuable!
Recently we brought you a list of the Top 20 Medical Apps Reviewed by MDLinx. Those apps were selected for their broad appeal across all medical specialties. The response to that post was very enthusiastic, so we've decided to explore some of the apps we like within individual specialties.
In this week's post, we will highlight the most promising apps in Oncology and Hematology. These apps offer valuable, on-the-go answers on overall topics in cancer…decision making in therapeutics…radiation oncology…blood cell morphology…and genetic targets for cancer treatment.
Look for more app highlights in other specialties coming soon…tell us what you think…and let us know if we've overlooked any apps that you find valuable!